CNS Pharmaceuticals, Inc. - stock earnings
CNSP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.5 million USD | ? USD |
| 2023Q2 | -4.0 million USD | ? USD |
| 2023Q1 | -4.9 million USD | ? USD |
| 2022Q4 | -5.5 million USD | ? USD |
| 2022Q3 | -3.4 million USD | ? USD |
| 2022Q2 | -3.6 million USD | ? USD |
| 2022Q1 | -2.8 million USD | ? USD |
| 2021Q4 | -2.8 million USD | ? USD |
| 2021Q3 | -3.8 million USD | ? USD |
| 2021Q2 | -3.8 million USD | ? USD |
| 2021Q1 | -3.6 million USD | ? USD |
| 2020Q4 | -3.0 million USD | ? USD |
| 2020Q3 | -2.0 million USD | ? USD |
| 2020Q2 | -2.5 million USD | ? USD |
| 2020Q1 | -2.0 million USD | ? USD |
| 2019Q4 | -2.5 million USD | ? USD |
| 2019Q3 | -706655 USD | ? USD |
| 2019Q2 | -431707 USD | ? USD |
| 2019Q1 | -211501 USD | ? USD |
| 2018Q4 | -6.6 million USD | ? USD |
| 2018Q3 | -193204 USD | ? USD |
| 2018Q2 | -257483 USD | ? USD |
CNSP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -18.6 million USD | ? USD |
| 2022 | -15.3 million USD | ? USD |
| 2021 | -14.0 million USD | ? USD |
| 2020 | -9.5 million USD | ? USD |
| 2019 | -3.9 million USD | ? USD |
| 2018 | -7.4 million USD | ? USD |
| 2017 | -219360 USD | ? USD |
CNSP
Price: $0.22
52 week price:
Earnings Per Share: -10.00 USD
P/E Ratio: -0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 89600
Market Capitalization: 2.6 million